Snowflake Synergy Mendel's Hypercube Platform is now available natively on Snowflake AI Data Cloud and integrates with Snowflake's Data Cloud, creating a joint value proposition for healthcare and life sciences teams already using Snowflake. This enables a cross-sell and co-sell opportunity with Snowflake's healthcare customers, leveraging Mendel's explainable clinical reasoning to improve data analysis and decision support.

TryMe Advantage The TryMe launch creates a low-friction pilot path for clinicians, researchers, CROs, and health systems to experience the platform with their data, accelerating qualification and proof of value for clinical data workflows.

Clinical AI Differentiation Mendel's proprietary clinical hypergraph and emphasis on explainability and reducing hallucinations address critical regulatory and safety concerns, making it attractive to pharma, CROs, and academic medical centers seeking auditable AI for trial design, real-world evidence, and cohort selection.

Market Fit Target With a mid-market sized team and blue-chip backing, Mendel appears well positioned to scale across health systems, pharma, and research organizations, focusing on use cases like clinical research, real-world evidence, and patient cohort discovery.

Growth Partnerships Strong funding, strategic investors, and ongoing Snowflake integration signal a growth trajectory and potential for channel partnerships with cloud and data-platform ecosystems to accelerate go-to-market and enterprise adoption.